<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1466491</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2024.1466491</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mast cells: a double-edged sword in inflammation and fibrosis</article-title>
<alt-title alt-title-type="left-running-head">Wang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2024.1466491">10.3389/fcell.2024.1466491</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xufang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1922152/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Peipei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1077962/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Yuxin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yanlin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Enchao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gao</surname>
<given-names>Kun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/656486/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Jiangsu Province Key Laboratory of Tonifying Kidney and Anti-senescence</institution>, <institution>Department of Nephrology</institution>, <institution>Jiangsu Province Hospital of Chinese Medicine</institution>, <institution>Affiliated Hospital of Nanjing University of Chinese Medicine</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/83669/overview">Katarzyna Nazimek</ext-link>, Jagiellonian University Medical College, Poland</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1308884/overview">Gregorio Gomez</ext-link>, University of Houston, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Kun Gao, <email>dr.gaokun@outlook.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>09</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1466491</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>07</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Wang, Zhang, Tang, Chen, Zhou and Gao.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Wang, Zhang, Tang, Chen, Zhou and Gao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>As one of the key components of the immune system, mast cells are well known for their role in allergic reactions. However, they are also involved in inflammatory and fibrotic processes. Mast cells participate in all the stages of acute inflammatory responses, playing an immunomodulatory role in both innate and adaptive immunity. Mast cell-derived histamine, TNF-&#x3b1;, and IL-6 contribute to the inflammatory processes, while IL-10 mediates the suppression of inflammation. Crosstalk between mast cells and other immune cells is also involved in the development of inflammation. The cell&#x2013;cell adhesion of mast cells and fibroblasts is crucial for fibrosis. Mast cell mediators, including cytokines and proteases, play contradictory roles in the fibrotic process. Here, we review the double-edged role of mast cells in inflammation and fibrosis.</p>
</abstract>
<kwd-group>
<kwd>mast cell</kwd>
<kwd>inflammation</kwd>
<kwd>fibrosis</kwd>
<kwd>fibroblast</kwd>
<kwd>innate immunity</kwd>
<kwd>adaptive immunity</kwd>
</kwd-group>
<contract-num rid="cn001">82104750 82274432</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular and Cellular Pathology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Mast cells (MCs) are important components of the innate and adaptive immune system (<xref ref-type="bibr" rid="B72">Tikoo et al., 2018</xref>). MCs are found in almost all kinds of tissues and organs, especially at sites close to the external environments, such as mucosal membranes, the skin, and perivascular areas, acting as sentinels (<xref ref-type="bibr" rid="B56">Piliponsky and Romani, 2018</xref>). The role of MCs has been widely investigated in allergic diseases such as urticaria, asthma, and rhinitis. It has been reported that the mediators released by activated MCs are crucial in allergic diseases (<xref ref-type="bibr" rid="B5">Anastasia et al., 2024</xref>). A protective role of mast cells in allergic responses has been reported recently (<xref ref-type="bibr" rid="B71">Thomas et al., 2023</xref>; <xref ref-type="bibr" rid="B25">Esther et al., 2023</xref>). These studies show the biphasic role of MCs in allergy. Because MCs are also demonstrated to be involved in inflammation and fibrosis (<xref ref-type="bibr" rid="B60">Ribatti et al., 2020</xref>; <xref ref-type="bibr" rid="B31">Guo et al., 2023</xref>), we will discuss the activating and inhibitory effects of MCs in these processes.</p>
<p>Using single-cell transcriptomics analysis, scientists proved that MCs derived from CD34<sup>&#x2b;</sup> pluripotent progenitor cells reside in the bone marrow (<xref ref-type="bibr" rid="B78">Wu et al., 2022</xref>). Mast cell progenitors leave the bone marrow and migrate into peripheral tissue, where they finish the process of maturation (<xref ref-type="bibr" rid="B67">Tahereh et al., 2022</xref>). Stem cell factor (SCF), which is the ligand of CD117, plays an important role in almost every stage of MC differentiation (<xref ref-type="bibr" rid="B69">Terhorst-Molawi et al., 2023</xref>). Mature MCs express a variety of stimulatory and inhibitory receptors on the cell surface (<xref ref-type="bibr" rid="B20">Daniel et al., 2019</xref>). Once activated through stimulatory receptors, MCs might release granules that contain a variety of mediators, including preformed mediators, newly synthesized lipid mediators, cytokines, and chemokines (<xref ref-type="bibr" rid="B55">Petri and Ilze, 2017</xref>). Due to the diversity of mediators in different MC subtypes, human mast cells are divided into two major subtypes: mast cells whose granules contain mostly tryptase (MC_T) and mast cells whose granules contain tryptase and chymase (MC_TC) (<xref ref-type="bibr" rid="B7">Baba et al., 2017</xref>). However, an intermediate phenotype linked to both MC_T and MC_TC was observed in human airway tissues (<xref ref-type="bibr" rid="B23">Dwyer et al., 2021</xref>). Another study identified six mast cell clusters in different human tissues (<xref ref-type="bibr" rid="B68">Tauber et al., 2023</xref>). These studies showed the natural diversity and heterogeneity of mast cells.</p>
</sec>
<sec id="s2">
<title>2 Mast cells in acute inflammatory responses</title>
<sec id="s2-1">
<title>2.1 Mast cells in innate immunity</title>
<p>MCs are involved in innate inflammatory responses such as bacterial infection, venom damage, and tissue injury (<xref ref-type="bibr" rid="B18">Chompunud Na Ayudhya et al., 2020</xref>). MCs express a variety of stimulatory receptors that function in innate immunity (<xref ref-type="bibr" rid="B20">Daniel et al., 2019</xref>). Agonists of toll-like receptors and Mas-related G protein-coupled receptors (MRGPR), complement anaphylatoxins C3a and C5a, and endogenous peptides are involved in mast cell activation (<xref ref-type="bibr" rid="B17">Cho et al., 2021</xref>; <xref ref-type="bibr" rid="B63">Roy et al., 2021</xref>; <xref ref-type="bibr" rid="B40">Laumonnier et al., 2023</xref>). Unlike the adaptive signals, the innate stimuli lead to the release of small and spherical granules rapidly through the activation of MCs. Those small granules induce local and transient inflammation in innate inflammatory responses (<xref ref-type="bibr" rid="B29">Gaudenzio et al., 2016</xref>). Previous studies showed that the activation of MRGPRX2 enhanced the clearance of <italic>Staphylococcus aureus</italic> from infected mouse skin (<xref ref-type="bibr" rid="B6">Arifuzzaman et al., 2019</xref>). MCs were also demonstrated to protect against snake and honeybee toxins by releasing proteases (<xref ref-type="bibr" rid="B84">Yuki et al., 2023</xref>). In addition, substance P (SP) could activate Mrgprb2 and mediate thermal hyperalgesia and non-histaminergic itch (<xref ref-type="bibr" rid="B30">Green et al., 2019</xref>; <xref ref-type="bibr" rid="B49">Meixiong et al., 2019</xref>). These studies revealed the proinflammatory role of MCs in innate immunity.</p>
<p>A series of three successive phases had been described in the acute inflammatory responses (<xref ref-type="bibr" rid="B4">Aller et al., 2004</xref>). MCs were shown to be involved in all three stages (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B3">Aller et al., 2019</xref>). The first phase of acute inflammation is the nervous phase, which manifests as vascular permeability changes through sensory and motor alterations. The activation of the hypothalamic&#x2013;pituitary&#x2013;adrenal axes and sympathetic nervous system was observed in acute tissue injury. In the immediate phase of inflammation, crosstalk of MCs and sensory nerves was crucial (<xref ref-type="bibr" rid="B73">Toyoshima and Okayama, 2022</xref>). Activation of the neuroendocrine system induces the release of activating signals, including adenosine, corticotrophin-releasing hormone, and substance P. Those stimuli could activate MCs. Activated MCs then release mediators such as histamine, vascular endothelial growth factor (VEGF), and prostacyclin, which increase vascular permeability and smooth muscle contraction. In addition, histamine, tryptase, and nerve growth factors released by MCs could stimulate nerve fibers and amplify the inflammatory courses.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Role of mast cells in acute inflammatory processes. Mast cells are involved in innate and adaptive immunity in the three stages of acute inflammation. In addition to IL-10, most mast cell mediators are proinflammatory. Crosstalk between mast cells and macrophages, dendritic cells, and neutrophils contributes to innate immunity, while the interaction of mast cells with B cells and T cells contributes to adaptive immunity. Crosstalk between mast cells and Treg has been shown to be immunosuppressive in inflammatory processes.</p>
</caption>
<graphic xlink:href="fcell-12-1466491-g001.tif"/>
</fig>
<p>In the later phase of inflammation, also called the immune phase, cytokines released by MCs contribute to the recruitment and maturation of other immune cells, such as macrophages, dendritic cells, and neutrophils. In this stage, MCs mainly play immunoregulatory roles in innate and adaptive immunity. Focusing on innate inflammation, MCs have been shown to contribute to macrophage recruitment and polarization by releasing cytokines such as monocyte chemotactic protein-1 (MCP-1) (<xref ref-type="bibr" rid="B24">Elieh Ali Komi et al., 2020</xref>; <xref ref-type="bibr" rid="B86">Zhang et al., 2020</xref>). MCs can also modulate neutrophils and dendritic cells. In the process of tissue injury, perivascular MCs were demonstrated to induce neutrophil recruitment and activation through the release of tumor necrosis factor (TNF)-&#x3b1; and interleukin (IL)-17a (<xref ref-type="bibr" rid="B34">Jan et al., 2021</xref>; <xref ref-type="bibr" rid="B36">Katia et al., 2013</xref>; <xref ref-type="bibr" rid="B59">R&#xe9;gis et al., 2022</xref>). Moreover, during bacterial infection, MC-derived leukotriene B4 (LTB4) contributed to host defense by mediating early neutrophil influx and bacterial clearance (<xref ref-type="bibr" rid="B75">Van Bruggen et al., 2023</xref>). Similarly, MC-derived TNF-&#x3b1; and IL-6 were shown to promote the migration and maturation of dendritic cells (<xref ref-type="bibr" rid="B35">Jan et al., 2015</xref>; <xref ref-type="bibr" rid="B22">Dudeck et al., 2019</xref>). Furthermore, MC-derived IL-4 mediated dendritic cell activation at the site of inflammation (<xref ref-type="bibr" rid="B26">Friedel et al., 2024</xref>). These results show that mast cells, macrophages, neutrophils, and dendritic cells comprise an important barrier of innate immunity.</p>
<p>Finally, in the last phase of acute inflammation, referred to as the endocrine phase, MCs could influence the microenvironment by inducing fibrogenesis and angiogenesis. MC-derived transforming growth factor (TGF)-&#x3b2;, VEGF, and fibroblast growth factor (FGF) are involved in this stage (<xref ref-type="bibr" rid="B39">Kyritsi et al., 2021</xref>). Those mediators are also essential in chronic inflammation and fibrosis.</p>
</sec>
<sec id="s2-2">
<title>2.2 Mast cells in adaptive immunity</title>
<p>MCs are believed to be a critical bridge in the transition from innate to adaptive immunity (<xref ref-type="bibr" rid="B12">Cardamone et al., 2016</xref>). MCs express high-affinity immunoglobulin E (IgE) receptors and several low-affinity IgG receptors on the cell surface (<xref ref-type="bibr" rid="B20">Daniel et al., 2019</xref>). These receptors allow antibodies to enroll MCs into immune responses in the presence of antigens. The role of MCs has been widely investigated in IgE-induced anaphylaxis (<xref ref-type="bibr" rid="B21">Dispenza et al., 2023</xref>). IgE and the high-affinity IgE receptors on MCs were also shown to be crucial for acquired resistance to honeybee venom (<xref ref-type="bibr" rid="B47">Marichal et al., 2013</xref>). In addition, the crosstalk between MCs and adaptive immune cells, including B cells and T cells, was essential for adaptive immunity.</p>
<p>MCs have been found to induce the activation and differentiation of B cells both in mouse models and humans (<xref ref-type="bibr" rid="B11">Breitling et al., 2017</xref>; <xref ref-type="bibr" rid="B64">Rurik et al., 2021</xref>). Direct cell&#x2013;cell contact was reported between MCs and B cells. The CD40-CD40L interaction play- a key role in MC-mediated B-cell activation (<xref ref-type="bibr" rid="B32">Gwan Ui et al., 2015</xref>; <xref ref-type="bibr" rid="B77">Viviana et al., 2020</xref>). In addition, MC-derived IL-6 was involved in B cell differentiation and immunoglobulin A (IgA) secretion (<xref ref-type="bibr" rid="B51">Merluzzi et al., 2010</xref>; <xref ref-type="bibr" rid="B74">Valeri et al., 2021</xref>). Because B-cell-derived IgE could re-activate MCs and result in more mediator release, MC-B-cell interaction might exaggerate the adaptive inflammatory responses.</p>
<p>Human MCs were shown to release chemokines such as chemokine (C-C motif) ligand (CCL)3 and CCL5 to recruit cytotoxic cells, including CD8&#x2b;T cells, during virus infection (<xref ref-type="bibr" rid="B82">Yana et al., 2021</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2023</xref>). MC-derived LTB4 and TNF-&#x3b1; were crucial for the amplifying of CD8<sup>&#x2b;</sup> T cells dominated adaptive immunity (<xref ref-type="bibr" rid="B35">Jan et al., 2015</xref>; <xref ref-type="bibr" rid="B10">Bodduluri et al., 2018</xref>). MCs were shown to be capable of antigen presentation via major histocompatibility complex (MHC) class I molecules to CD8&#x2b;T cells (<xref ref-type="bibr" rid="B62">R et al., 1996</xref>). This crosstalk proved to be important in regulating CD8&#x2b;T-cell proliferation, cytokine secretion, and cytotoxic activity. MCs were demonstrated to express costimulatory molecules OX40L for T-cell activation in human skin (<xref ref-type="bibr" rid="B48">Marta et al., 2014</xref>). Similarly, MCs are involved in the recruitment, activation, and differentiation of CD4<sup>&#x2b;</sup> T cells. Most of the modulating function of MCs on CD4<sup>&#x2b;</sup> T cells depends on the expression of MHC class &#x2161; molecules and OX40L (<xref ref-type="bibr" rid="B65">Sahar et al., 2017</xref>). TNF-&#x3b1; and IL-6 are also crucial in establishing synaptic contacts (<xref ref-type="bibr" rid="B53">Nicolas et al., 2013</xref>). Interestingly, evidence showed that MCs treated with nicotinamide adenine dinucleotide (NAD)&#x2b; could mediate CD4<sup>&#x2b;</sup> T-cell differentiation independently of MHC II and T-cell receptor signaling machinery (<xref ref-type="bibr" rid="B33">Hector et al., 2018</xref>).</p>
<p>In addition to the roles of initiator and effector in innate immunity, MCs are also important in the host&#x2019;s transition from innate to adaptive immunity. The crosstalk between MCs and other immune cells indicated the immunomodulatory ability of MCs. The immunomodulatory ability might be more important than the effector-cell function under given circumstances. Further exploration is needed to understand how to regulate MCs in inflammatory processes.</p>
</sec>
<sec id="s2-3">
<title>2.3 Role of mast cells in the suppression of inflammatory responses</title>
<p>MCs were demonstrated to be suppressors of inflammatory responses. The anti-inflammatory role of MCs is partially dependent on the release of IL-10. Using three different types of MC-deficient mice and mice with ablated MC-derived IL-10, researchers showed that MC-derived IL-10 could limit inflammation and tissue pathology in contact hypersensitivity (<xref ref-type="bibr" rid="B58">Reber et al., 2017</xref>). In another study using IL-33 for the activation of synovial MCs, researchers found that the production of IL-10 and histamine was elevated, resulting in the suppression of monocyte-mediated disease activity in rheumatoid arthritis (<xref ref-type="bibr" rid="B61">Rivellese et al., 2015</xref>). MC-derived IL-10 also functions in graft-versus-host disease (GVHD). MC-derived IL-10 significantly reduced GVHD by decreasing conventional T-cell proliferation. This immunosuppressive ability was independent of Tregs (<xref ref-type="bibr" rid="B41">Leveson-Gower et al., 2013</xref>). In experimental murine myeloperoxidase (MPO)-ANCA-associated vasculitis (AAV), MC-derived IL-10 enhanced the immunosuppressive function of Treg and played a protective role in MPO-related inflammation (<xref ref-type="bibr" rid="B28">Gan et al., 2012</xref>; <xref ref-type="bibr" rid="B27">Gan et al., 2016</xref>).</p>
<p>In addition to IL-10, the immunosuppressive function of MCs also depends on the crosstalk of MCs and regulatory T cells. IL-9 produced by Treg is important in MC recruitment and activation, which then mediate regional immune suppression in tolerant allografts. MC-deficient mice are not capable of establishing long-term allograft tolerance (<xref ref-type="bibr" rid="B42">Li-Fan et al., 2006</xref>). In addition, MC-derived IL-2 is involved in suppressing chronic allergic dermatitis by promoting Treg expansion (<xref ref-type="bibr" rid="B37">Keith et al., 2023</xref>). MCs are also crucial for the resistance of streptozotocin-induced type 1 diabetes mellitus by promoting Treg-mediated immunological tolerance (<xref ref-type="bibr" rid="B13">Carlos et al., 2015</xref>).</p>
<p>Although many studies have discussed the proinflammatory and anti-inflammatory roles of MCs, it is still unclear which signals mediate the immunosuppressive function of MCs. One study showed that the MC stabilizer disodium cromoglycate inhibited MC degranulation without affecting IL-10 production and resulted in the protection of AAV disease activity (<xref ref-type="bibr" rid="B27">Gan et al., 2016</xref>). This study suggested that some medications might limit the deleterious function and retain the protective ability of MCs. Perhaps there will be more targeted treatments that regulate the function of MCs in inflammatory processes in the future.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Mast cells and fibrosis</title>
<sec id="s3-1">
<title>3.1 Mast cells in the activation of fibroblasts</title>
<p>The transition of fibroblasts into myofibroblasts was shown to induce excessive deposition of extracellular matrix and then cause fibrosis in different tissues and organs (<xref ref-type="bibr" rid="B83">Younesi et al., 2024</xref>). Crosstalk between MCs and fibroblasts has been investigated in recent decades (<xref ref-type="fig" rid="F2">Figure 2</xref>). One study showed that co-culture of dermal fibroblasts with human MC significantly enhanced contraction of the three-dimensional collagen lattices; the addition of antibodies against stem cell factor (SCF) and c-kit resulted in the inhibition of gel contraction. Nevertheless, adding the supernatants of MCs to cultured fibroblasts did not enhance the speed of gel contraction, which indicates the importance of cell&#x2013;cell contact (<xref ref-type="bibr" rid="B81">Yamamoto et al., 2000</xref>). Several studies showed cell adhesion between MCs and fibroblasts (<xref ref-type="bibr" rid="B80">Yaksh et al., 2019</xref>; <xref ref-type="bibr" rid="B57">Pincha et al., 2018</xref>). Murine MCs adhere to fibroblasts through SCF-KIT interaction (<xref ref-type="bibr" rid="B1">Adachi et al., 1992</xref>), while the adhesion of human MCs and fibroblasts depends on the expression of the cell adhesion molecule (CADM)1-kit mechanism (<xref ref-type="bibr" rid="B52">Moiseeva et al., 2013</xref>). This cell&#x2013;cell adhesion is the foundation of contact-dependent cell communication.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Crosstalk between mast cells and fibroblasts in fibrotic processes. The cell&#x2013;cell adhesion between mast cells and fibroblasts depends on the stem cell factor-Kit (SCF-KIT) interaction. In addition, mast cell-derived cytokines and chemokines contribute to the transition of fibroblasts into myofibroblasts. Interestingly, some mast cell mediators have been shown to have both profibrotic and antifibrotic functions.</p>
</caption>
<graphic xlink:href="fcell-12-1466491-g002.tif"/>
</fig>
<p>In addition to the contact-dependent cell communication, mediators released by both cells are crucial in the MC-fibroblast crosstalk. It is believed that fibroblasts triggered MC activation through the production of SCF (<xref ref-type="bibr" rid="B44">Luo et al., 2022</xref>). Meanwhile, several MC-derived mediators, such as TGF-&#x3b2;, are involved in activating fibroblasts. TNF-&#x3b1; was shown to be crucial for the MC-fibroblast interaction in myocardial fibrosis (<xref ref-type="bibr" rid="B85">Zhang et al., 2011</xref>). MC-derived IL-13/IL-4 is involved in disease progression in myelofibrosis (<xref ref-type="bibr" rid="B50">Melo-Cardenas et al., 2022</xref>). MCs could release IL-33, which stimulates fibroblasts and enhances collagen expression (<xref ref-type="bibr" rid="B79">Wulff et al., 2019</xref>). MC tryptase was demonstrated to induce lung fibroblast migration via protease-activated receptor-2 (PAR-2) activation (<xref ref-type="bibr" rid="B8">Bagher et al., 2018</xref>). In addition, MC tryptase was shown to promote inflammatory bowel disease-induced intestinal fibrosis through the PAR-2/Akt/mammalian target of the rapamycin (mTOR) pathway of fibroblasts (<xref ref-type="bibr" rid="B43">Liu et al., 2021</xref>). MC chymase was found to promote fibroblast proliferation and collagen synthesis through the activation of the TGF-&#x3b2;1/Smads signaling pathway (<xref ref-type="bibr" rid="B14">Chen et al., 2017</xref>). Chymase was also shown to be a major source of angiotensin II (Ang II) production (<xref ref-type="bibr" rid="B2">Ahmad and Ferrario, 2018</xref>), and Ang II was widely investigated for its pro-fibrosis role in different diseases (<xref ref-type="bibr" rid="B45">Lv et al., 2021</xref>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Mast cells in the inhibition of fibrosis</title>
<p>An antifibrotic role of MCs was also observed in several studies. One study observed the difference between the unilateral ureteral obstruction (UUO) model in W/W<sup>v</sup> mice and the UUO model in the wild type. Higher levels of renal interstitium fibrosis, more infiltrating immune cells, and higher tissue levels of TGF-&#x3b2;1 were observed in MC-deficient mice, which indicated the protective role of MCs in renal fibrosis. A possible explanation of the protective role of MCs was that MC-derived heparin could inhibit TGF-&#x3b2;1 production (<xref ref-type="bibr" rid="B38">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="B9">Beghdadi et al., 2013</xref>). As mentioned above, MCs could produce anti-inflammatory mediators, including IL-10 and IL-33 (<xref ref-type="bibr" rid="B66">Stephen et al., 2020</xref>). IL-10 has been shown to attenuate cardiac fibrosis by inhibiting TGF-&#x3b2;-induced myofibroblast differentiation (<xref ref-type="bibr" rid="B76">Verma et al., 2017</xref>). Another study observed that IL-33 impaired fibroblast migration and gel contraction in age-related macular degeneration (<xref ref-type="bibr" rid="B70">Theodoropoulou et al., 2015</xref>). Because IL-33 has been reported for its profibrotic role in diseased states, the function of IL-33 in fibrosis might be contradictory. Another MC mediator was proved to be both profibrotic and antifibrotic. MC chymase was shown to protect against renal fibrosis by activating matrix metalloproteinases and degrading interstitial deposits of fibronectin (<xref ref-type="bibr" rid="B9">Beghdadi et al., 2013</xref>; <xref ref-type="bibr" rid="B46">MacColl and Khalil, 2015</xref>).</p>
</sec>
<sec id="s3-3">
<title>3.3 Confounding factors of mast cells in fibrosis</title>
<p>Unlike the role of MCs in the inflammatory process, the role of MCs in fibrosis is more complicated. The anti-inflammatory function of MCs is mostly mediated by IL-10 and crosstalk between MCs and regular T cells. However, in fibrotic processes, both a profibrotic and antifibrotic role can be observed in a specific MC-derived mediator. In addition, results from cell culture and animal models are often contradictory. One explanation is that some of the MC-deficient animal models are not appropriate for the study under the given circumstances. Some reactions have been demonstrated to be induced by the other consequences of the genetic mutation instead of the absence of MCs (<xref ref-type="bibr" rid="B16">Chmela&#x159; et al., 2016</xref>). The different types of stimuli may also be responsible for the paradoxical results. The reactions of MCs are not consistent for acute tissue injury and chronic tissue damage. One study investigated the role of MCs in both the early and late phases in murine models of acute and chronic renal ischemia-reperfusion injury (IRI). MCs were found to promote fibrosis in the acute phase of IRI but not in the chronic phase of the disease (<xref ref-type="bibr" rid="B19">Danelli et al., 2017</xref>). Moreover, the most widely used MC stabilizers, disodium cromoglycate and ketotifen, can inhibit IgE-mediated MC degranulation but have no impact on mediators independently of degranulation. A high concentration of disodium cromoglycate has an effect beyond its inhibition on MCs (<xref ref-type="bibr" rid="B54">Oka et al., 2012</xref>). This makes targeting the antifibrotic effects of MCs more challenging.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>The heterogeneity and diversity of mediators make the role of MCs contradictory in inflammation and fibrosis. For further research, animal models should be carefully selected to eliminate the effect of MCs. Using two or more MC-deficient animal models, as well as MC-engrafted methods, will be more precise than using one single animal model. In addition, most research animal models are designed for acute injury; perhaps an animal model of chronic damage may reflect the functions of MCs in chronic inflammation and fibrosis more exactly. Moreover, the specificity of MC stabilizers is not satisfactory; targeting a single mediator of MCs will be more important in research and clinical applications.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Author contributions</title>
<p>XW: conceptualization, writing&#x2013;original draft, writing&#x2013;review and editing. PZ: data curation, writing&#x2013;review and editing. YT: writing&#x2013;review and editing. YC: writing&#x2013;review and editing. EZ: supervision, validation, writing&#x2013;review and editing. KG: conceptualization, supervision, validation, writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s6">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (82104750 AND 82274432).</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adachi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ebi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kasugai</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>Necessity of extracellular domain of W (C-kit) receptors for attachment of murine cultured mast cells to fibroblasts</article-title>. <source>Blood</source> <volume>79</volume> (<issue>3</issue>), <fpage>650</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1182/blood.v79.3.650.650</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferrario</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018)</article-title>. <source>Expert Opin. Ther. Pat.</source> <volume>28</volume> (<issue>11</issue>), <fpage>755</fpage>&#x2013;<lpage>764</lpage>. <comment>Epub 20181010</comment>. <pub-id pub-id-type="doi">10.1080/13543776.2018.1531848</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aller</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Carcinogenesis: the cancer cell-mast cell connection</article-title>. <source>Inflamm. Res.</source> <volume>68</volume> (<issue>2</issue>), <fpage>103</fpage>&#x2013;<lpage>116</lpage>. <comment>Epub 20181120</comment>. <pub-id pub-id-type="doi">10.1007/s00011-018-1201-4</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aller</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Nava</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Arias</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems</article-title>. <source>Exp. Biol. Med. (Maywood)</source> <volume>229</volume> (<issue>2</issue>), <fpage>170</fpage>&#x2013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1177/153537020422900206</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anastasia</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Maxim</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Boris</surname>
<given-names>V. C.</given-names>
</name>
<name>
<surname>Maria</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>The role played by autophagy in fc&#x3b5;ri-dependent activation of mast cells</article-title>. <source>Cells</source> <volume>13</volume> (<issue>8</issue>), <fpage>690</fpage>. <pub-id pub-id-type="doi">10.3390/cells13080690</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arifuzzaman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mobley</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Bist</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>Z. D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Mrgpr-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection</article-title>. <source>Sci. Adv.</source> <volume>5</volume> (<issue>1</issue>), <fpage>eaav0216</fpage>. <comment>Epub 20190102</comment>. <pub-id pub-id-type="doi">10.1126/sciadv.aav0216</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Suzukawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ohta</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamasoba</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Distribution, subtype population, and ige positivity of mast cells in chronic rhinosinusitis with nasal polyps</article-title>. <source>Ann. Allergy Asthma Immunol.</source> <volume>119</volume> (<issue>2</issue>), <fpage>120</fpage>&#x2013;<lpage>128</lpage>. <comment>Epub 20170619</comment>. <pub-id pub-id-type="doi">10.1016/j.anai.2017.05.019</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagher</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Larsson-Callerfelt</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Rosmark</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Hallgren</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bjermer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Westergren-Thorsson</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2</article-title>. <source>Cell Commun. Signal</source> <volume>16</volume> (<issue>1</issue>), <fpage>59</fpage>. <comment>Epub 20180915</comment>. <pub-id pub-id-type="doi">10.1186/s12964-018-0269-3</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beghdadi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Madjene</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Claver</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pejler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Beaudoin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lehuen</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction</article-title>. <source>Kidney Int.</source> <volume>84</volume> (<issue>2</issue>), <fpage>317</fpage>&#x2013;<lpage>326</lpage>. <comment>Epub 20130320</comment>. <pub-id pub-id-type="doi">10.1038/ki.2013.98</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bodduluri</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Mathis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maturu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Krishnan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Satpathy</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Chilton</surname>
<given-names>P. M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Mast cell-dependent Cd8(&#x2b;) T-cell recruitment mediates immune surveillance of intestinal tumors in apc(min/&#x2b;) mice</article-title>. <source>Cancer Immunol. Res.</source> <volume>6</volume> (<issue>3</issue>), <fpage>332</fpage>&#x2013;<lpage>347</lpage>. <comment>Epub 20180130</comment>. <pub-id pub-id-type="doi">10.1158/2326-6066.Cir-17-0424</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breitling</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zabini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>N. M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>The mast cell-B cell Axis in lung vascular remodeling and pulmonary hypertension</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>312</volume> (<issue>5</issue>), <fpage>L710-L721</fpage>&#x2013;<lpage>l21</lpage>. <comment>Epub 20170224</comment>. <pub-id pub-id-type="doi">10.1152/ajplung.00311.2016</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardamone</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Parente</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Feo</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Triggiani</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Mast cells as effector cells of innate immunity and regulators of adaptive immunity</article-title>. <source>Immunol. Lett.</source> <volume>178</volume>, <fpage>10</fpage>&#x2013;<lpage>14</lpage>. <comment>Epub 20160705</comment>. <pub-id pub-id-type="doi">10.1016/j.imlet.2016.07.003</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yaochite</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Toso</surname>
<given-names>V. D.</given-names>
</name>
<name>
<surname>Malmegrim</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>S. G.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Mast cells control insulitis and increase Treg cells to confer protection against stz-induced type 1 diabetes in mice</article-title>. <source>Eur. J. Immunol.</source> <volume>45</volume> (<issue>10</issue>), <fpage>2873</fpage>&#x2013;<lpage>2885</lpage>. <comment>Epub 20150814</comment>. <pub-id pub-id-type="doi">10.1002/eji.201545498</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Mast cell chymase promotes hypertrophic scar fibroblast proliferation and collagen synthesis by activating TGF-&#x3b2;1/Smads signaling pathway</article-title>. <source>Exp. Ther. Med.</source> <volume>14</volume> (<issue>5</issue>), <fpage>4438</fpage>&#x2013;<lpage>4442</lpage>. <comment>Epub 20170831</comment>. <pub-id pub-id-type="doi">10.3892/etm.2017.5082</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>C. E. M.</given-names>
</name>
<name>
<surname>Bulfone-Paus</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Exploring mast cell-Cd8 T cell interactions in inflammatory skin diseases</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume> (<issue>2</issue>), <fpage>1564</fpage>. <comment>Epub 20230113</comment>. <pub-id pub-id-type="doi">10.3390/ijms24021564</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chmela&#x159;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chatzigeorgiou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Prucnal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Voehringer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Roers</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>No role for mast cells in obesity-related metabolic dysregulation</article-title>. <source>Front. Immunol.</source> <volume>7</volume>, <fpage>524</fpage>. <comment>Epub 20161124</comment>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00524</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>S. Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Toll-like receptor 7 (Tlr7) mediated transcriptomic changes on human mast cells</article-title>. <source>Ann. Dermatol</source> <volume>33</volume> (<issue>5</issue>), <fpage>402</fpage>&#x2013;<lpage>408</lpage>. <comment>Epub 20210908</comment>. <pub-id pub-id-type="doi">10.5021/ad.2021.33.5.402</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chompunud Na Ayudhya</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thapaliya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Roles of a mast cell-specific receptor Mrgprx2 in host defense and inflammation</article-title>. <source>J. Dent. Res.</source> <volume>99</volume> (<issue>8</issue>), <fpage>882</fpage>&#x2013;<lpage>890</lpage>. <comment>Epub 20200511</comment>. <pub-id pub-id-type="doi">10.1177/0022034520919107</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Madjene</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Madera-Salcedo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gautier</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pacreau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ben</surname>
<given-names>M. S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Early phase mast cell activation determines the chronic outcome of renal ischemia-reperfusion injury</article-title>. <source>J. Immunol.</source> <volume>198</volume> (<issue>6</issue>), <fpage>2374</fpage>&#x2013;<lpage>2382</lpage>. <comment>Epub 20170206</comment>. <pub-id pub-id-type="doi">10.4049/jimmunol.1601282</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniel</surname>
<given-names>E. A. K.</given-names>
</name>
<name>
<surname>Stefan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mast cell biology at molecular level: a comprehensive review</article-title>. <source>Clin. Rev. Allergy Immunol.</source> <volume>58</volume> (<issue>3</issue>), <fpage>342</fpage>&#x2013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1007/s12016-019-08769-2</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dispenza</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Metcalfe</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Olivera</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Research advances in mast cell biology and their translation into novel therapies for anaphylaxis</article-title>. <source>J. Allergy Clin. Immunol. Pract.</source> <volume>11</volume> (<issue>7</issue>), <fpage>2032</fpage>&#x2013;<lpage>2042</lpage>. <comment>Epub 20230321</comment>. <pub-id pub-id-type="doi">10.1016/j.jaip.2023.03.015</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dudeck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Froebel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kotrba</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>C. H. K.</given-names>
</name>
<name>
<surname>Dudziak</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Speier</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Engulfment of mast cell secretory granules on skin inflammation boosts dendritic cell migration and priming efficiency</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>143</volume> (<issue>5</issue>), <fpage>1849</fpage>&#x2013;<lpage>1864</lpage>. <comment>Epub 20181017</comment>. <pub-id pub-id-type="doi">10.1016/j.jaci.2018.08.052</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dwyer</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Ordovas-Montanes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Allon</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Buchheit</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Vukovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Derakhshan</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation</article-title>. <source>Sci. Immunol.</source> <volume>6</volume> (<issue>56</issue>), <fpage>eabb7221</fpage>. <pub-id pub-id-type="doi">10.1126/sciimmunol.abb7221</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elieh Ali Komi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shafaghat</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Christian</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Crosstalk between mast cells and adipocytes in physiologic and pathologic conditions</article-title>. <source>Clin. Rev. Allergy Immunol.</source> <volume>58</volume> (<issue>3</issue>), <fpage>388</fpage>&#x2013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1007/s12016-020-08785-7</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esther</surname>
<given-names>B. F.</given-names>
</name>
<name>
<surname>Nathaniel</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Jaime</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Bruna</surname>
<given-names>G. C. L.</given-names>
</name>
<name>
<surname>Mahdieh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fernando</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Immune sensing of food allergens promotes avoidance behaviour</article-title>. <source>Nature</source> <volume>620</volume> (<issue>7974</issue>), <fpage>643</fpage>&#x2013;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-023-06362-4</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pierre</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kolbinger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sch&#xe4;ufele</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Aliraj</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Weigert</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Mast cell-derived interleukin-4 mediates activation of dendritic cell during toll-like receptor 2-mediated inflammation</article-title>. <source>Front. Immunol.</source> <volume>15</volume>, <fpage>1353922</fpage>. <comment>Epub 20240430</comment>. <pub-id pub-id-type="doi">10.3389/fimmu.2024.1353922</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gan</surname>
<given-names>P. Y.</given-names>
</name>
<name>
<surname>O&#x27;Sullivan</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Alikhan</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Odobasic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Mast cell stabilization ameliorates autoimmune anti-myeloperoxidase glomerulonephritis</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>27</volume> (<issue>5</issue>), <fpage>1321</fpage>&#x2013;<lpage>1333</lpage>. <comment>Epub 20150915</comment>. <pub-id pub-id-type="doi">10.1681/asn.2014090906</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gan</surname>
<given-names>P. Y.</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>O&#x27;Sullivan</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Muljadi</surname>
<given-names>R. C.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis</article-title>. <source>J. Am. Soc. Nephrol.</source> <volume>23</volume> (<issue>12</issue>), <fpage>1955</fpage>&#x2013;<lpage>1966</lpage>. <comment>Epub 20121108</comment>. <pub-id pub-id-type="doi">10.1681/asn.2012060572</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaudenzio</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sibilano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marichal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Starkl</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reber</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Cenac</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Different activation signals induce distinct mast cell degranulation strategies</article-title>. <source>J. Clin. Invest</source> <volume>126</volume> (<issue>10</issue>), <fpage>3981</fpage>&#x2013;<lpage>3998</lpage>. <comment>Epub 20160919</comment>. <pub-id pub-id-type="doi">10.1172/jci85538</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Limjunyawong</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gour</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pundir</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A mast-cell-specific receptor mediates neurogenic inflammation and pain</article-title>. <source>Neuron</source> <volume>101</volume> (<issue>3</issue>), <fpage>412</fpage>&#x2013;<lpage>420</lpage>. <comment>Epub 20190124</comment>. <pub-id pub-id-type="doi">10.1016/j.neuron.2019.01.012</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers</article-title>. <source>Eur. J. Pharmacol.</source> <volume>960</volume>, <fpage>176103</fpage>. <comment>Epub 20231016</comment>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2023.176103</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gwan Ui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ji Yeun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nam Goo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Joo-Ho</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jai Youl</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Ige and iga produced by ox40-ox40l or Cd40-Cd40l interaction in B cells-mast cells Re-activate fc&#x3b5;ri or fc&#x3b1;ri on mast cells in mouse allergic asthma</article-title>. <source>Eur. J. Pharmacol.</source> <volume>754</volume> (<issue>0</issue>), <fpage>199</fpage>&#x2013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2015.02.023</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hector</surname>
<given-names>R. C. B.</given-names>
</name>
<name>
<surname>Timm</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hirofumi</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Virginia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koichiro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yeqi</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Mast cells regulate Cd4(&#x2b;) T-cell differentiation in the absence of antigen presentation</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>142</volume> (<issue>6</issue>), <fpage>1894</fpage>&#x2013;<lpage>1908.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2018.01.038</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Johanna</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Roland</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aaron</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Vasileia Ismini</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation</article-title>. <source>Immunity</source> <volume>54</volume> (<issue>3</issue>), <fpage>468</fpage>&#x2013;<lpage>483.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2020.12.017</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shanawaz</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Christian</surname>
<given-names>H. K. L.</given-names>
</name>
<name>
<surname>Anja</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nadja</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sergei</surname>
<given-names>A. N.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Mast-cell-derived tnf amplifies Cd8(&#x2b;) dendritic cell functionality and Cd8(&#x2b;) T cell priming</article-title>. <source>Cell Rep.</source> <volume>13</volume> (<issue>2</issue>), <fpage>399</fpage>&#x2013;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.08.078</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katia</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Anne</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mike</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Emma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nico</surname>
<given-names>vR.</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Mast cell and macrophage chemokines cxcl1/cxcl2 control the early stage of neutrophil recruitment during tissue inflammation</article-title>. <source>Blood</source> <volume>121</volume> (<issue>24</issue>), <fpage>4930</fpage>&#x2013;<lpage>4937</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2013-02-486217</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keith</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Egawa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kabashima</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Mast cells in type 2 skin inflammation: maintenance and function</article-title>. <source>Eur. J. Immunol.</source> <volume>53</volume> (<issue>8</issue>), <fpage>e2250359</fpage>. <comment>Epub 20230407</comment>. <pub-id pub-id-type="doi">10.1002/eji.202250359</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Mast cells decrease renal fibrosis in unilateral ureteral obstruction</article-title>. <source>Kidney Int.</source> <volume>75</volume> (<issue>10</issue>), <fpage>1031</fpage>&#x2013;<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2009.1</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyritsi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Meadows</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hargrove</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Demieville</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mast cells induce ductular reaction mimicking liver injury in mice through mast cell-derived transforming growth factor beta 1 signaling</article-title>. <source>Hepatology</source> <volume>73</volume> (<issue>6</issue>), <fpage>2397</fpage>&#x2013;<lpage>2410</lpage>. <comment>Epub 20210419</comment>. <pub-id pub-id-type="doi">10.1002/hep.31497</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laumonnier</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Korkmaz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nowacka</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>K&#xf6;hl</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Complement-mediated immune mechanisms in allergy</article-title>. <source>Eur. J. Immunol.</source> <volume>53</volume> (<issue>10</issue>), <fpage>e2249979</fpage>. <comment>Epub 20230709</comment>. <pub-id pub-id-type="doi">10.1002/eji.202249979</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leveson-Gower</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Sega</surname>
<given-names>E. I.</given-names>
</name>
<name>
<surname>Kalesnikoff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Florek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pierini</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Mast cells suppress murine gvhd in a mechanism independent of Cd4&#x2b;Cd25&#x2b; regulatory T cells</article-title>. <source>Blood</source> <volume>122</volume> (<issue>22</issue>), <fpage>3659</fpage>&#x2013;<lpage>3665</lpage>. <comment>Epub 20130912</comment>. <pub-id pub-id-type="doi">10.1182/blood-2013-08-519157</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li-Fan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Evan</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Kathy</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Michael</surname>
<given-names>W. G.</given-names>
</name>
<name>
<surname>Karina</surname>
<given-names>P.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Mast cells are essential intermediaries in regulatory T-cell tolerance</article-title>. <source>Nature</source> <volume>442</volume> (<issue>7106</issue>), <fpage>997</fpage>&#x2013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1038/nature05010</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M. Q.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T. Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mast cell tryptase promotes inflammatory bowel disease-induced intestinal fibrosis</article-title>. <source>Inflamm. Bowel Dis.</source> <volume>27</volume> (<issue>2</issue>), <fpage>242</fpage>&#x2013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1093/ibd/izaa125</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Stem cell factor/mast cell/ccl2/monocyte/macrophage Axis promotes coxsackievirus B3 myocarditis and cardiac fibrosis by increasing ly6c(high) monocyte influx and fibrogenic mediators production</article-title>. <source>Immunology</source> <volume>167</volume> (<issue>4</issue>), <fpage>590</fpage>&#x2013;<lpage>605</lpage>. <comment>Epub 20220823</comment>. <pub-id pub-id-type="doi">10.1111/imm.13556</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Z. F.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>W. Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W. Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y. F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Lp-Pla2 inhibition prevents Ang ii-induced cardiac inflammation and fibrosis by blocking macrophage Nlrp3 inflammasome activation</article-title>. <source>Acta Pharmacol. Sin.</source> <volume>42</volume> (<issue>12</issue>), <fpage>2016</fpage>&#x2013;<lpage>2032</lpage>. <comment>Epub 20210705</comment>. <pub-id pub-id-type="doi">10.1038/s41401-021-00703-7</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacColl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Khalil</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>355</volume> (<issue>3</issue>), <fpage>410</fpage>&#x2013;<lpage>428</lpage>. <comment>Epub 20150828</comment>. <pub-id pub-id-type="doi">10.1124/jpet.115.227330</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marichal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Starkl</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reber</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Kalesnikoff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oettgen</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>A beneficial role for immunoglobulin E in host defense against honeybee venom</article-title>. <source>Immunity</source> <volume>39</volume> (<issue>5</issue>), <fpage>963</fpage>&#x2013;<lpage>975</lpage>. <comment>Epub 20131024</comment>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.005</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marta</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Federica</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Alfredo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Patrick</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vladimir</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Amos</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Abnormal interactions between perifollicular mast cells and Cd8&#x2b; T-cells may contribute to the pathogenesis of alopecia areata</article-title>. <source>PLoS One</source> <volume>9</volume> (<issue>5</issue>), <fpage>e94260</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0094260</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meixiong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Limjunyawong</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sabbagh</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>M. R.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Activation of mast-cell-expressed mas-related G-protein-coupled receptors drives non-histaminergic itch</article-title>. <source>Immunity</source> <volume>50</volume> (<issue>5</issue>), <fpage>1163</fpage>&#x2013;<lpage>1171</lpage>. <comment>Epub 20190423</comment>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.013</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melo-Cardenas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bezavada</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Gurbuxani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cotton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Il-13/Il-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms</article-title>. <source>Blood</source> <volume>140</volume> (<issue>26</issue>), <fpage>2805</fpage>&#x2013;<lpage>2817</lpage>. <pub-id pub-id-type="doi">10.1182/blood.2022017326</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merluzzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Frossi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Parusso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tripodo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pucillo</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward iga-secreting plasma cells</article-title>. <source>Blood</source> <volume>115</volume> (<issue>14</issue>), <fpage>2810</fpage>&#x2013;<lpage>2817</lpage>. <comment>Epub 20100125</comment>. <pub-id pub-id-type="doi">10.1182/blood-2009-10-250126</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moiseeva</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Roach</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Leyland</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Bradding</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Cadm1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>4</issue>), <fpage>e61579</fpage>. <comment>Epub 20130419</comment>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061579</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicolas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Camille</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Salvatore</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Eric</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Human mast cells drive memory Cd4&#x2b; T cells toward an inflammatory il-22&#x2b; phenotype</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>131</volume> (<issue>5</issue>), <fpage>1400</fpage>&#x2013;<lpage>1407</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2013.01.029</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kalesnikoff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Starkl</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Evidence questioning cromolyn&#x27;s effectiveness and selectivity as a &#x27;mast cell stabilizer&#x27; in mice</article-title>. <source>Lab. Invest</source> <volume>92</volume> (<issue>10</issue>), <fpage>1472</fpage>&#x2013;<lpage>1482</lpage>. <comment>Epub 20120820</comment>. <pub-id pub-id-type="doi">10.1038/labinvest.2012.116</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petri</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Ilze</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Mast cells in atherosclerotic cardiovascular disease - activators and actions</article-title>. <source>Eur. J. Pharmacol.</source> <volume>816</volume> (<issue>0</issue>), <fpage>37</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2017.10.013</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piliponsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Romani</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The contribution of mast cells to bacterial and fungal infection immunity</article-title>. <source>Immunol. Rev.</source> <volume>282</volume> (<issue>1</issue>), <fpage>188</fpage>&#x2013;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12623</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pincha</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hajam</surname>
<given-names>E. Y.</given-names>
</name>
<name>
<surname>Badarinath</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Batta</surname>
<given-names>S. P. R.</given-names>
</name>
<name>
<surname>Masudi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Pai1 mediates fibroblast-mast cell interactions in skin fibrosis</article-title>. <source>J. Clin. Invest</source> <volume>128</volume> (<issue>5</issue>), <fpage>1807</fpage>&#x2013;<lpage>1819</lpage>. <comment>Epub 20180326</comment>. <pub-id pub-id-type="doi">10.1172/jci99088</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reber</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Sibilano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Starkl</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Roers</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grimbaldeston</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Imaging protective mast cells in living mice during severe contact hypersensitivity</article-title>. <source>JCI Insight</source> <volume>2</volume> (<issue>9</issue>), <fpage>e92900</fpage>. <comment>Epub 20170504</comment>. <pub-id pub-id-type="doi">10.1172/jci.insight.92900</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>R&#xe9;gis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Idaira Mar&#xed;a</surname>
<given-names>G.-F.</given-names>
</name>
<name>
<surname>Tamara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jonathon</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Monja</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Laura</surname>
<given-names>V.-M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Neutrophil breaching of the blood vessel pericyte layer during diapedesis Requires mast cell-derived il-17a</article-title>. <source>Nat. Commun.</source> <volume>13</volume> (<issue>1</issue>), <fpage>7029</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-34695-7</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribatti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tamma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Annese</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mast cells and angiogenesis in multiple sclerosis</article-title>. <source>Inflamm. Res.</source> <volume>69</volume> (<issue>11</issue>), <fpage>1103</fpage>&#x2013;<lpage>1110</lpage>. <comment>Epub 20200817</comment>. <pub-id pub-id-type="doi">10.1007/s00011-020-01394-2</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivellese</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Suurmond</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Habets</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dorj&#xe9;e</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Ramamoorthi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Townsend</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Ability of interleukin-33- and immune complex-triggered activation of human mast cells to down-regulate monocyte-mediated immune responses</article-title>. <source>Arthritis Rheumatol.</source> <volume>67</volume> (<issue>9</issue>), <fpage>2343</fpage>&#x2013;<lpage>2353</lpage>. <pub-id pub-id-type="doi">10.1002/art.39192</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>R</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>N</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>E</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>S</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>J</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Mast cells process bacterial ags through a phagocytic route for class I mhc presentation to T cells</article-title>. <source>J. Immunol.</source> <volume>156</volume> (<issue>4</issue>), <fpage>1490</fpage>&#x2013;<lpage>1496</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.156.4.1490</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chompunud Na Ayudhya</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thapaliya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Deepak</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Multifaceted Mrgprx2: new insight into the role of mast cells in health and disease</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>148</volume> (<issue>2</issue>), <fpage>293</fpage>&#x2013;<lpage>308</lpage>. <comment>Epub 20210504</comment>. <pub-id pub-id-type="doi">10.1016/j.jaci.2021.03.049</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rurik</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Aghajanian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Immune cells and immunotherapy for cardiac injury and repair</article-title>. <source>Circ. Res.</source> <volume>128</volume> (<issue>11</issue>), <fpage>1766</fpage>&#x2013;<lpage>1779</lpage>. <comment>Epub 20210527</comment>. <pub-id pub-id-type="doi">10.1161/circresaha.121.318005</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahar</surname>
<given-names>L.-E.</given-names>
</name>
<name>
<surname>Brant</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Quang</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Andrea</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Masoud</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Judith</surname>
<given-names>A. W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Human mast cells present antigen to autologous Cd4(&#x2b;) T cells</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>141</volume> (<issue>1</issue>). <pub-id pub-id-type="doi">10.1016/j.jaci.2017.02.048</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephen</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mindy</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mast cells in inflammation and disease: recent progress and ongoing concerns</article-title>. <source>Annu. Rev. Immunol.</source> <volume>38</volume> (<issue>0</issue>), <fpage>49</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-071719-094903</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tahereh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Joshua</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Daniel</surname>
<given-names>F. D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Defining mast cell differentiation and heterogeneity through single-cell transcriptomics analysis</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>150</volume> (<issue>4</issue>), <fpage>739</fpage>&#x2013;<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2022.08.011</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tauber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Basso</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bostan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Thierry</surname>
<given-names>G. R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Landscape of mast cell populations across organs in mice and humans</article-title>. <source>J. Exp. Med.</source> <volume>220</volume> (<issue>10</issue>), <fpage>e20230570</fpage>. <comment>Epub 20230718</comment>. <pub-id pub-id-type="doi">10.1084/jem.20230570</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terhorst-Molawi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hawro</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Grekowitz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kiefer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Merchant</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alvarado</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Anti-kit antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria</article-title>. <source>Allergy</source> <volume>78</volume> (<issue>5</issue>), <fpage>1269</fpage>&#x2013;<lpage>1279</lpage>. <comment>Epub 20221203</comment>. <pub-id pub-id-type="doi">10.1111/all.15585</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theodoropoulou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Copland</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dick</surname>
<given-names>A. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Role of interleukin 33/st2 Axis in the immune-mediated pathogenesis of age-related macular degeneration</article-title>. <source>Lancet</source> <volume>385</volume> (<issue>Suppl. 1</issue>), <fpage>S97</fpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(15)60412-3</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rebecca</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fuwei</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Daniel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Candice</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Mast cells link immune sensing to antigen-Avoidance behaviour</article-title>. <source>Nature</source> <volume>620</volume> (<issue>7974</issue>), <fpage>634</fpage>&#x2013;<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-023-06188-0</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tikoo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Barki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zulkhernain</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Buhner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schemann</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Imaging of mast cells</article-title>. <source>Immunol. Rev.</source> <volume>282</volume> (<issue>1</issue>), <fpage>58</fpage>&#x2013;<lpage>72</lpage>. <comment>Epub 2018/02/13</comment>. <pub-id pub-id-type="doi">10.1111/imr.12631</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toyoshima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Okayama</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Neuro-allergology: mast cell-nerve cross-talk</article-title>. <source>Allergol. Int.</source> <volume>71</volume> (<issue>3</issue>), <fpage>288</fpage>&#x2013;<lpage>293</lpage>. <comment>Epub 20220607</comment>. <pub-id pub-id-type="doi">10.1016/j.alit.2022.04.002</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valeri</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tonon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vibhushan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gulino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Belmonte</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Adori</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mast cells crosstalk with B cells in the gut and sustain iga response in the inflamed intestine</article-title>. <source>Eur. J. Immunol.</source> <volume>51</volume> (<issue>2</issue>), <fpage>445</fpage>&#x2013;<lpage>458</lpage>. <comment>Epub 20201014</comment>. <pub-id pub-id-type="doi">10.1002/eji.202048668</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Bruggen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jarrot</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sheehy</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>C. M. S.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>A. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Nlrp3 is essential for neutrophil polarization and chemotaxis in response to leukotriene B4 gradient</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>120</volume> (<issue>35</issue>), <fpage>e2303814120</fpage>. <comment>Epub 20230821</comment>. <pub-id pub-id-type="doi">10.1073/pnas.2303814120</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verma</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Garikipati</surname>
<given-names>V. N. S.</given-names>
</name>
<name>
<surname>Krishnamurthy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Grisanti</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Cimini</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Interleukin-10 inhibits bone marrow fibroblast progenitor cell-mediated cardiac fibrosis in pressure-overloaded myocardium</article-title>. <source>Circulation</source> <volume>136</volume> (<issue>10</issue>), <fpage>940</fpage>&#x2013;<lpage>953</lpage>. <comment>Epub 20170630</comment>. <pub-id pub-id-type="doi">10.1161/circulationaha.117.027889</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viviana</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Silvia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shamila</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Alessandro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Beatrice</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Monika</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Mast cells crosstalk with B cells in the gut and sustain iga response in the inflamed intestine</article-title>. <source>Eur. J. Immunol.</source> <volume>51</volume> (<issue>2</issue>), <fpage>445</fpage>&#x2013;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1002/eji.202048668</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Boey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bril</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Grootens</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vijayabaskar</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Sorini</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors</article-title>. <source>Blood Adv.</source> <volume>6</volume> (<issue>15</issue>), <fpage>4439</fpage>&#x2013;<lpage>4449</lpage>. <pub-id pub-id-type="doi">10.1182/bloodadvances.2022006969</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wulff</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Pappa</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Wilgus</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Interleukin-33 encourages scar formation in murine fetal skin wounds</article-title>. <source>Wound Repair Regen.</source> <volume>27</volume> (<issue>1</issue>), <fpage>19</fpage>&#x2013;<lpage>28</lpage>. <comment>Epub 20181123</comment>. <pub-id pub-id-type="doi">10.1111/wrr.12687</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaksh</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Eddinger</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Kokubu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>DiNardo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ramachandran</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Mast cell degranulation and fibroblast activation in the morphine-induced spinal mass: role of mas-related G protein-coupled receptor signaling</article-title>. <source>Anesthesiology</source> <volume>131</volume> (<issue>1</issue>), <fpage>132</fpage>&#x2013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1097/aln.0000000000002730</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Eckes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Krieg</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/C-kit</article-title>. <source>Immunology</source> <volume>99</volume> (<issue>3</issue>), <fpage>435</fpage>&#x2013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2567.2000.00973.x</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yana</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Max</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Marcus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Melba</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mast cells modulate antigen-specific Cd8(&#x2b;) T cell activation during lcmv infection</article-title>. <source>Front. Immunol.</source> <volume>12</volume> (<issue>0</issue>), <fpage>688347</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.688347</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Younesi</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>F. M. V.</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Fibroblast and myofibroblast activation in normal tissue repair and fibrosis</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>25</volume> (<issue>8</issue>), <fpage>617</fpage>&#x2013;<lpage>638</lpage>. <comment>Epub 20240408</comment>. <pub-id pub-id-type="doi">10.1038/s41580-024-00716-0</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuki</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tatsuro</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Toko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akane</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kosuke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Takahisa</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Mast cell-derived prostaglandin D(2) limits the subcutaneous absorption of honey bee venom in mice</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>120</volume> (<issue>22</issue>), <fpage>e2300284120</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2300284120</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chancey</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Tzeng</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lavine</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions</article-title>. <source>Circulation</source> <volume>124</volume> (<issue>19</issue>), <fpage>2106</fpage>&#x2013;<lpage>2116</lpage>. <comment>Epub 20111024</comment>. <pub-id pub-id-type="doi">10.1161/circulationaha.111.052399</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Ige contributes to atherosclerosis and obesity by affecting macrophage polarization, macrophage protein network, and foam cell formation</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source> <volume>40</volume> (<issue>3</issue>), <fpage>597</fpage>&#x2013;<lpage>610</lpage>. <comment>Epub 20200130</comment>. <pub-id pub-id-type="doi">10.1161/atvbaha.119.313744</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>